Silence Therapeutics plc
SLN
$3.36
-$0.15-4.27%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/28/2025
-
MarketBeat
4/26/2025
-
Ticker Report
4/26/2025
-
Ticker Report
4/24/2025
-
Insider Monkey
4/20/2025
-
MarketBeat
4/16/2025
-
ETF Channel
3/28/2025
-
Tickeron - Stocks
3/24/2025
-
MarketBeat
3/22/2025
-
Simply Wall St
3/18/2025
-
Tickeron - Technical Analysis
3/15/2025
-
Tickeron - Stocks
3/11/2025
-
Tickeron - Stocks
3/11/2025
-
Tickeron - Stocks
3/8/2025
-
Tickeron - Technical Analysis
3/8/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/6/2025
-
Simply Wall St
3/5/2025
-
MarketBeat
3/5/2025
-
GuruFocus
3/5/2025
-
Business Wire
3/4/2025
-
Benzinga
3/4/2025
-
Simply Wall St
3/4/2025
-
Zacks Investment Research
3/4/2025
-
MarketBeat
3/4/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 3457 6900
Address
72 Hammersmith Road
London, W14 8TH
London, W14 8TH
Country
Year Founded
Business Description
Sector
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of...
more